EP2658992A4 - Biomarqueurs protéiques du cancer du sein de stade tardif - Google Patents

Biomarqueurs protéiques du cancer du sein de stade tardif

Info

Publication number
EP2658992A4
EP2658992A4 EP11853637.4A EP11853637A EP2658992A4 EP 2658992 A4 EP2658992 A4 EP 2658992A4 EP 11853637 A EP11853637 A EP 11853637A EP 2658992 A4 EP2658992 A4 EP 2658992A4
Authority
EP
European Patent Office
Prior art keywords
breast cancer
late stage
protein biomarkers
stage breast
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11853637.4A
Other languages
German (de)
English (en)
Other versions
EP2658992A2 (fr
Inventor
David B Krizman
Marlene M Darfler
Thomas P Conrads
Brian L Hood
Nicholas W Bateman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Expression Pathology Inc
Original Assignee
Expression Pathology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expression Pathology Inc filed Critical Expression Pathology Inc
Publication of EP2658992A2 publication Critical patent/EP2658992A2/fr
Publication of EP2658992A4 publication Critical patent/EP2658992A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP11853637.4A 2010-12-29 2011-12-29 Biomarqueurs protéiques du cancer du sein de stade tardif Withdrawn EP2658992A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428160P 2010-12-29 2010-12-29
PCT/US2011/068000 WO2012092532A2 (fr) 2010-12-29 2011-12-29 Biomarqueurs protéiques du cancer du sein de stade tardif

Publications (2)

Publication Number Publication Date
EP2658992A2 EP2658992A2 (fr) 2013-11-06
EP2658992A4 true EP2658992A4 (fr) 2015-05-20

Family

ID=46383872

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11853637.4A Withdrawn EP2658992A4 (fr) 2010-12-29 2011-12-29 Biomarqueurs protéiques du cancer du sein de stade tardif

Country Status (5)

Country Link
EP (1) EP2658992A4 (fr)
JP (1) JP2014513790A (fr)
AU (1) AU2011351993A1 (fr)
CA (1) CA2823339A1 (fr)
WO (1) WO2012092532A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109315384A (zh) * 2018-11-12 2019-02-12 西南医科大学 一种乳腺癌组织的转移及冻存方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) * 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
US20090263842A1 (en) * 2006-03-24 2009-10-22 Expression Pathology Method of assessing the metastatic status of a primary tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5166250B2 (ja) * 2005-05-25 2013-03-21 エクスプレッション、パソロジー、インコーポレイテッド 組織病理学的に処理した生物学的試料からのプロテオームの適用範囲を増加させるための、液体組織標品を用いたマルチプレックス方法
EP1961825A1 (fr) * 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Procédé pour prévoir l'apparition de métastase dans les patients souffrant d'un cancer du sein
WO2009126969A2 (fr) * 2008-04-11 2009-10-15 Expression Pathology Inc. Biomarqueurs pour maladie endométriale

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) * 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
US20090263842A1 (en) * 2006-03-24 2009-10-22 Expression Pathology Method of assessing the metastatic status of a primary tumor

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABBA MARTIN C ET AL: "Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression", BREAST CANCER RESEARCH, CURRENT SCIENCE, LONDON, GB, vol. 6, no. 5, 6 July 2004 (2004-07-06), pages R499 - R513, XP021012063, ISSN: 1465-5411, DOI: 10.1186/BCR899 *
ABD EL-REHIM M A ET AL: "HIGH-THROUGHPUT PROTEIN EXPRESSION ANALYSIS USING TISSUE MICROARRAY TECHNOLOGY OF A LARGE WELL-CHARACTERISED SERIES IDENTIFIES BIOLOGICALLY DISTINCT CLASSES OF BREAST CANCER CONFIRMING RECENT CDNA EXPRESSION ANALYSES", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, vol. 116, no. 3, 7 April 2005 (2005-04-07), pages 340 - 350, XP009051968, ISSN: 0020-7136, DOI: 10.1002/IJC.21004 *
KAREN S. ANDERSON ET AL: "Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer", JOURNAL OF PROTEOME RESEARCH, vol. 10, no. 1, 26 October 2010 (2010-10-26), pages 85 - 96, XP055012289, ISSN: 1535-3893, DOI: 10.1021/pr100686b *
MA X-J ET AL: "Gene expression profiles of human breast cancer progression", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 10, 13 May 2003 (2003-05-13), pages 5974 - 5979, XP002615160, ISSN: 0027-8424, [retrieved on 20030424], DOI: 10.1073/PNAS.0931261100 *
SINGLETARY S EVA ET AL: "Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual", SURGICAL CLINICS OF NORTH AMERICA, SAUNDERS, PHILADELPHIA, US, vol. 83, no. 4, 1 August 2003 (2003-08-01), pages 803 - 819, XP009181675, ISSN: 0039-6109 *
SOMIARI R I ET AL: "Proteomics of breast carcinoma", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 815, no. 1-2, 5 February 2005 (2005-02-05), pages 215 - 225, XP027627444, ISSN: 1570-0232, [retrieved on 20050205] *

Also Published As

Publication number Publication date
CA2823339A1 (fr) 2012-07-05
JP2014513790A (ja) 2014-06-05
WO2012092532A2 (fr) 2012-07-05
AU2011351993A1 (en) 2013-07-18
EP2658992A2 (fr) 2013-11-06
WO2012092532A3 (fr) 2014-02-27

Similar Documents

Publication Publication Date Title
IL290139A (en) Optimization of multigene analysis of tumor samples
IL276488B (en) A method for predicting breast cancer prognosis
EP2625292A4 (fr) Biomarqueurs de cancer
EP2536854A4 (fr) Biomarqueurs tumoraux personnalisés
HK1198867A1 (en) Treatment of breast cancer
PL2558854T3 (pl) Biomarkery będące krążącymi kwasami nukleinowymi związanymi z rakiem piersi
EP2542583B8 (fr) Méthodes de traitement du cancer du sein
GB2513275B (en) Biomarkers for Breast Cancer Prediction and Diagnosis
EP2698634A4 (fr) Biomarqueur pour le cancer du sein
EP2648762A4 (fr) Pronostic du cancer du sein après traitement
PT2550296T (pt) Anticorpos monoclonais para tratamento do cancro
GB2509682B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
WO2012018877A9 (fr) Traitement du cancer du sein avec un anticorps anti-il-19
GB2510539B (en) Biomarkers of cancer
EP2649225A4 (fr) Biomarqueurs pour la prédiction du cancer du sein
EP2707720A4 (fr) Diagnostic et pronostic de cancer du sein triple-négatif et de l'ovaire
EP2501845A4 (fr) Biomarqueurs de cancer
EP2659272A4 (fr) Biomarqueurs protéiques de cancer du sein récurrent
EP2658992A4 (fr) Biomarqueurs protéiques du cancer du sein de stade tardif
GB201004304D0 (en) Biomarkers for prostate cancer
EP2769225A4 (fr) Marqueurs biologiques prédictifs pour le cancer du sein
EP2721410A4 (fr) Biomarqueurs destinés au diagnostic et au traitement d'un cancer épithélial
GB201115736D0 (en) Novel biomarkers for breast tumours from hsp70-associated peptides
IL223237A0 (en) Diagnosis of cancer
GB201002366D0 (en) Cancer prognosis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130729

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

R17D Deferred search report published (corrected)

Effective date: 20140227

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/37 20060101AFI20141215BHEP

Ipc: G01N 33/68 20060101ALI20141215BHEP

Ipc: G01N 33/574 20060101ALI20141215BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20150417

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/574 20060101ALI20150413BHEP

Ipc: C12Q 1/37 20060101AFI20150413BHEP

Ipc: G01N 33/68 20060101ALI20150413BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20150527